Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

87181 Press Releases
DateTitleCompany
01 Sep 15 Audentes Therapeutics Acquires Cardiac Gene Therapy Company Cardiogen Sciences Audentes Therapeutics, Inc.,
Published by
Business Wire
01 Sep 15 Navitor Pharmaceuticals Appoints David M. Madden to Board of Directors and Michael N. Hall, PhD, to Scientific Advisory Board Navitor Pharmaceuticals, Inc.,
Published by
Business Wire
01 Sep 15 BioTime Chief Executive Officer Dr. Michael D. West to be Keynote Speaker at Stem Cells & Regenerative Medicine Congress 2015 BioTime, Inc.,
Published by
Business Wire
01 Sep 15 U.S. Food and Drug Administration Accepts for Priority Review the Biologics License Application for Empliciti (elotuzumab) for the Treatment of Multiple Myeloma in Patients Who Have Received One or More Prior Therapies Bristol-Myers Squibb Company,
Published by
Business Wire
01 Sep 15 NeuroVive Announces Departure of CEO and Appointment of Jan Nilsson as Interim CEO Neurovive Pharmaceutical,
Published by
Business Wire
01 Sep 15 ArcherDX Launches VariantPlex™ p53 Panel for Targeted NGS ArcherDX, Inc.,
Published by
Business Wire
01 Sep 15 Crescendo Bioscience Names Elena Hitraya M.D., Ph.D., as Chief Medical Officer Published by
GlobeNewswire
01 Sep 15 Galena Biopharma to Present at Two Upcoming Healthcare Investment Conferences Published by
GlobeNewswire
01 Sep 15 XBiotech Advances Phase 1/2 Clinical Study of Novel True Human(TM) Therapeutic Antibody for Treating Serious Infections Due to Staphylococcus Aureus Published by
GlobeNewswire
01 Sep 15 Heat Biologics Announces Clinical Trial Combining HS-110 and PD-1 Checkpoint Inhibitor in NSCLC Published by
GlobeNewswire
01 Sep 15 Apricus Biosciences Announces the Launch of Its Novel Topical Treatment for Erectile Dysfunction in Italy by Bracco SpA Published by
GlobeNewswire
01 Sep 15 Matinas BioPharma Appoints Cochleate Technology Pioneer Raphael J. Mannino, Ph.D., as Senior Vice President and Chief Technology Officer Published by
GlobeNewswire
01 Sep 15 Kraig Biocraft Laboratories Moves Corporate Office to Michigan Hub for Genetic Engineering Research Published by
GlobeNewswire
01 Sep 15 Achillion to Present at Two Upcoming Investor Conferences Published by
GlobeNewswire
01 Sep 15 400th Lombard Medical Aorfix(TM) Endovascular Stent Graft Procedure Completed One Year Following Japanese Approval and Launch Published by
GlobeNewswire
01 Sep 15 H. Lundbeck A/S increases its share capital by 545,917 shares (0.2777 % of outstanding shares) as a result of employee warrant exercise Published by
GlobeNewswire
01 Sep 15 Apricus Biosciences Announces the Launch of Its Novel Topical Treatment for Erectile Dysfunction in Italy by Bracco SpA Apricus Biosciences, Inc.,
Published by
GlobeNewswire
01 Sep 15 Can-Fite to Present at Rodman & Renshaw 17th Annual Global Investment Conference on September 9, 2015 Can-Fite BioPharma Ltd.,
Published by
PR Newswire
01 Sep 15 SI-BONE, Inc. Appoints Karen Licitra and Keith Valentine to its Board of Directors SI-BONE, Inc.,
Published by
PR Newswire
01 Sep 15 CeQur Announces $100 Million Series C Financing CeQur SA,
Published by
PR Newswire
01 Sep 15 12th International Congress on AIDS in Asia Pacific (ICAAP12) Hosts Two-Day Marathon Meeting The International Congress on AIDS in Asia Pacific (ICAAP),
Published by
PR Newswire
01 Sep 15 The National Health Authority Bundesamt für Gesundheit Approves Reimbursement of XIFAXAN® 550 in Switzerland Norgine B.V.,
Published by
PR Newswire
01 Sep 15 Surefire Medical Receives FDA Clearance for Precision Direct-to-Tumor Embolization Device Surefire Medical, Inc.,
Published by
Business Wire
01 Sep 15 Illumina Completes Acquisition of GenoLogics Illumina, Inc.,
Published by
Business Wire
01 Sep 15 Opexa Secures Private Funding for its NMO Orphan Development Program, Including Planned Phase I/II Clinical Study Opexa Therapeutics, Inc.,
Published by
Business Wire
01 Sep 15 Intellia Therapeutics Secures $70 Million in Series B Financing Intellia Therapeutics,
Published by
Business Wire
01 Sep 15 Surgeons From World-Renowned NYC Surgical Lead the Way in the Eastern U.S. to Treat Vascular Disease & Disorders with ArtVentive EOS™, a Revolutionary New Device in Vascular Applications NYC Surgical Associates,
Published by
Business Wire
01 Sep 15 ObsEva Presents Pharmacology Data Showing that OBE001, the First Orally Active Oxytocin Antagonist, Inhibits not only Uterine Contractions but also Preterm Labor Related Inflammation Pathways Published by
GlobeNewswire
01 Sep 15 Covaris, Inc. and OmniSeq, LLC Today Announced truXTRAC™ FFPE DNA Extraction and Purification Kit as the Method of Choice for Obtaining Clinical-grade DNA from FFPE Samples for Use with OmniSeq Target(SM) Testing Covaris, Inc.,
Published by
PR Newswire
01 Sep 15 Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients Thrombosis Research Institute,
Published by
PR Newswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.